Resolution of risperidone-induced tardive dyskinesia with a switch to aripiprazole monotherapyChronic sleep deprivationCorticosteroneDNA damageRatsReboundSingle cell gel (comet) assayThe aim of this investigation was to evaluate genetic damage induced in male rats by experimental sleep loss for short-term ...
Compared to the first generation antipsychotics, the second-generation antipsychotics have a lower liability to develop TD (3-5).We present one female schizophrenic patient who developed TD after risperidone treatment and experienced a remarkable improvement with aripiprazole.Mrs C, a 39-year-old ...
A total of 500 patients were randomized and received iloperidone (gradual switch, 240; immediate switch, 260), with 175, 155, and 170 patients switched from risperidone, olanzapine, and aripiprazole, respectively. I-CGI-C Results confirmed improved outcomes at Week 12, with scores that were ...
Risperidone/zuclopenthixol: Symptomatic hyperprolactinaemia treated with aripiprazole switch: 5 case reports
adults diagnosed with schizophrenia experiencing inadequate efficacy and/or poor tolerability on risperidone, olanzapine, or aripiprazole were randomized to switch to iloperidone either gradually (ie, down-titration of current therapy over the first 2 weeks [to 50% on Day 1, 25% by Week 1, 0%...
Out of the total number of 113 patients treated with once-monthly injectable PP, 78 (69.03%) were on monotherapy, while 35 (30.97%) had one additional oral antipsychotic (risperidone, olanzapine, aripiprazole, or clozapine). Out of the total number of 113 patients, 68 (60.18%) we...
5 second-generation antipsychotics (aripiprazole, olanzapine, quetiapine, risperidone, and ziprasidone) were compared to haloperidol. In the mixed effects model the Risk Ratio for depressive switch was 0.71 (0.52, 0.96) favouring atypical antipsychotics. In the random effects model the difference did ...
For the four most frequently used oral SGAs, the median times to all-cause discontinuation for monotherapy and polypharmacy, respectively, were 192 and 100days for aripiprazole; 222 and 86days for olanzapine; 176 and 91days for quetiapine; and 157 and 93days for risperidone. For mortality and...
When examined by preswitch antipsychotic, significant improvements in PETiT total scores were observed in patients switched from quetiapine, risperidone, aripiprazole, and ziprasidone (all p???doi:10.1186/1471-244X-14-53Awad, GeorgeHassan, Mariam...